leadf
logo-loader
TSX-V:IGX

INTELGENX TECHNOLOGIES CORP.

Receive alerts
Market:
TSX-V
Market Cap:
$36.68 m
Price
0.33 CAD
Change
0.00%
52 weeks high
0.65
52 weeks low
0.16

In brief

IntelGenx Corp, through its cutting edge formulation platforms, has developed a broad and diverse product portfolio, including products for the treatment of indications such as severe depression, hypertension, erectile dysfunction, migraine, insomnia, CNS indications, idiopathic pulmonary fibrosis, oncology and pain, as well as animal health products.